IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
John Radcliffe Hospital · University of Oxford
Abstract
Results of experimental and genetic studies have highlighted the role of the IL-23/IL-17 axis in the pathogenesis of inflammatory bowel disease (IBD). IL-23-driven inflammation has been primarily linked to Th17 cells; however, we have recently identified a novel population of innate lymphoid cells (ILCs) in mice that produces IL-17, IL-22, and IFN-γ in response to IL-23 and mediates innate colitis. The relevance of ILC populations in human health and disease is currently poorly understood. In this study, we have analyzed the role of IL-23-responsive ILCs in the human intestine in control and IBD patients. Our results show increased expression of the Th17-associated cytokine genes IL17A and IL17F among…
Citation impact
- FWCI
- 18.56
- Percentile
- 100%
- References
- 32
Authors
8- AGAlessandra Geremia
John Radcliffe Hospital, University of Oxford
- CVCarolina V. Arancibia-Cárcamo
John Radcliffe Hospital, University of Oxford
- MFMyles Fleming
John Radcliffe Hospital, University of Oxford
- NRNigel Rust
John Radcliffe Hospital, University of Oxford
- BSBaljit Singh
John Radcliffe Hospital, University of Oxford
Topics & keywords
- Innate lymphoid cell
- Immunology
- Interleukin 22
- Inflammation
- Inflammatory bowel disease
- Interleukin 23
- Population
- Interleukin-7 receptor
- Good health and well-being